(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the ...

RSV infections affect a significant number of children under age 5, with considerable disease burden in primary care and EDs.

UMDHU is encouraging you to choose to be immunized against respiratory infections. Depending on your age and health factors, these could include influenza, respiratory syncytial virus (RSV) and ...

For the last three years, health care providers have warned of a "tripledemic," during which rising cases of COVID-19, the flu and respiratory syncytial virus, or RSV, potentially burden ...

Upper respiratory infections (URIs) are some of the most common infections and are caused by a variety of pathogens. Treatment for URIs is usually symptomatic only, if needed, unless a person also has ...

The Upper Missouri District Health Unit (UMDHU) is urging people to get immunizations against respiratory infections.

The National Respiratory Day returns on Saturday, September 21, organized by Aipo-Its/Ets (Italian Association of Hospital ...

But unlike influenza and COVID, there were at that time no Health Canada-approved immunization options for RSV, except for ...

The uncontrolled activity of some immune cells in the lungs impeded structural cells from repairing themselves.

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...

Moderna, Inc. announced that the European Commission (EC) has granted marketing authorization for mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV ... It causes a particularly high burden ...